Lafora Disease
Watchlist
Retrieved
2021-01-23
Source
Trials
—
Genes
NHLRC1,
EPM2A,
SNCA,
APOE,
CBLL2,
PRKN,
MUL1,
GBA,
CSTB,
NNAT,
CTSD,
LAMP2,
MAPT,
OPN1MW,
CYP2D6,
OPN1MW3,
EPM2AIP1,
LRRK2,
OPN1MW2,
SNCB,
LAMP1,
ATP13A2,
DNM1L,
BCKDK,
SQSTM1,
DENR,
KHDRBS1,
VCP,
LMTK2,
TRIM32
NHLRC1,
EPM2A,
SNCA,
APOE,
CBLL2,
PRKN,
MUL1,
GBA,
CSTB,
NNAT,
CTSD,
LAMP2,
MAPT,
OPN1MW,
CYP2D6,
OPN1MW3,
EPM2AIP1,
LRRK2,
OPN1MW2,
SNCB,
LAMP1,
ATP13A2,
DNM1L,
BCKDK,
SQSTM1,
DENR,
KHDRBS1,
VCP,
LMTK2,
TRIM32,
DNAJC13,
HIPK2,
TARDBP,
DAPK2,
MIR4697,
MICOS10-NBL1,
RMDN2,
STX1B,
MAP1LC3A,
PPP1R3B,
DCP1A,
SYBU,
RMDN3,
DCTN4,
CHCHD2,
RMDN1,
EJM2,
TTR,
NFU1,
BCL2L13,
NUP62,
UTRN,
ACHE,
HSP90B1,
CLN3,
GLUL,
GFAP,
FGFR3,
DSP,
CST3,
CRMP1,
CLN5,
TPP1,
GRN,
CHI3L1,
CASP2,
BDNF,
BCHE,
AR,
AMY2A,
GRK2,
GRK5,
GTF2H1,
SNCG,
PARN,
SLC1A2,
SCN1A,
ACP1,
PTEN,
PPP1R3C,
SERPINI1,
PFKL,
NGF,
GYG1,
NBL1,
MECP2,
KRAS,
INSRR,
HSPA5,
HSPA4,
HSF1,
PVALB
Drugs
Registered!
Lafora disease (LD) is a rare, inherited, severe, progressive myoclonic epilepsy characterized by myoclonus and/or generalized seizures, visual hallucinations (partial occipital seizures), and progressive neurological decline.